Sp. Rao et al., B19 PARVOVIRUS INFECTION IN CHILDREN WITH MALIGNANT SOLID TUMORS RECEIVING CHEMOTHERAPY, Medical and pediatric oncology, 22(4), 1994, pp. 255-257
Two children with rhabdomyosarcoma developed severe anemia following c
hemotherapy; anemia was more severe compared to that observed followin
g earlier chemotherapy cycles. While one patient had a brisk reticuloc
ytosis, the other had no demonstrable reticulocytes. Both patients had
evidence of acute B19 parvovirus infection and subsequently developed
appropriate antibody response. A diagnosis of B19 parvovirus infectio
n should be considered in any patient who develops persistent or sever
e anemia while on chemotherapy. (C) 1994 Wiley-Liss, Inc.